A novel prognostic model based on serum levels of total bilirubin and creatinine early after liver transplantation

Liver International

Volumn 27, Issue 6, 2007, Pages 816-824

  Xu, Xiao ^a   Ling, Qi ^a   Wu, Jian ^a   Chen, Jun ^a   Gao, Feng ^a   Feng, Xiao Ning ^a   Zheng, Shu Sen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Kidney function; Liver function; Liver transplantation; MELD; Prognosis

Indexed keywords

BILIRUBIN; CREATININE; CYCLOSPORIN; INTERLEUKIN 2 RECEPTOR ANTIBODY; TACROLIMUS;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; ROC CURVE; SCORING SYSTEM; SURVIVAL TIME; VALIDATION STUDY;

ADULT; BILIRUBIN; BIOLOGICAL MARKERS; CREATININE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY DISEASES; LIVER DISEASES; LIVER FAILURE; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 34447333650     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01494.x     Document Type: Article

References (43)

1. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
2. Wiesner RH, Mcdiarmid SV, Kamath PS, et al. MELD and PELD: Application of survival models to liver allocation. Liver Transpl 2001; 7: 567-80.
3. Brown RSJR, Kumar KS, Russo MW, et al. Model for end stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in united network for organ sharing status 2A patients. Liver Transpl 2002; 8: 278-84.
4. Wiesner R, Edwards E, Freeman R, et al. United network for organ sharing liver disease severity score committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-6.
5. Hayashi PH, Forman L, Steinberg T, et al. Model for end-stage liver disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl 2003; 9: 737-40.
6. Lee YM, Fernandez M, Da Costa M, et al. MELD may not be the better system for organ allocation in liver transplantation patients in Singapore. Singapore Med J 2006; 47: 592-4.
7. Fernandez-Aguilar JL, Santoyo J, Suarez MA, et al. Is MELD useful in evaluating surgical risk in liver transplantation candidates? Transplant Proc 2003; 35: 705-6.
8. Nagler E, Van Vlierberghe H, Colle I, et al. Impact of MELD on short-term and long-term outcome following liver transplantation: A European perspective. Eur J Gastroenterol Hepatol 2005; 17: 849-56.
9. Desai NM, Mange KC, Crawford MD, et al. Predicting outcome after liver transplantation: Utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004; 77: 99-106.
10. Jacob M, Copley LP, Lewsey JD, et al. Pre-transplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl 2004; 10: 903-7.
11. Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: A European study. Gut 2003; 52: 134-9.
12. Habib S, Berk B, Chang CC, et al. MELD and prediction of post-liver transplantation survival. Liver Transpl 2006; 12: 440-7.
13. Huo TI, Lin HC, Wu JC, et al. Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications. Clin Transplant 2006; 20: 188-94.
14. Ghobrial RM, Gornbein J, Steadman R, et al. Pre-transplant model to predict post-transplant survival in liver transplant patients. Ann Surg 2002; 236: 315-22, discussion 322-3.
15. Thuluvath PJ, Yoo HY, Thompson RE. A model to predict survival at one month, one year, and five years after liver transplantation based on pre-transplant clinical characteristics. Liver Transpl 2003; 9: 527-32.
16. Nair S, Verma S, Thuluvath PJ, et al. Pre-transplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002; 4: 1179-85.
17. Narayanan Menon KV, Nyberg SL, Harmsen WS, et al. MELD and other factors associated with survival after liver transplantation. Am J Transplant 2004; 4: 819-25.
18. Northup PG, Berg CL. Preoperative delta-MELD score does not independently predict mortality after liver transplantation. Am J Transplant 2004; 4: 1643-9.
19. Lebron Gallardo M, Herrera Gutierrez ME, Seller Perez G, et al. Risk factors for renal dysfunction in the postoperative course of liver transplant. Liver Transpl 2004; 10: 1379-85.
20. Cabezuelo JB, Ramirez P, Rios A, et al. Risk factors of acute renal failure after liver transplantation. Kidney Int 2006; 69: 1073-80.
21. Gainza FJ, Valdivieso A, Quintanilla N, et al. Evaluation of acute renal failure in the liver transplantation perioperative period: Incidence and impact. Transplant Proc 2002; 34: 250-1.
22. Pawarode A, Fine DM, Thuluvath PJ. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 2003; 9: 741-7.
23. Alvares-da-Silva MR, Waechter FL, Francisconi CF, et al. Risk factors for postoperative acute renal failure at a new orthotopic liver transplantation program. Transplant Proc 1999; 31: 3050-2.
24. Deschenes M, Belle SH, Krom RA, et al. Early allograft dysfunction after liver transplantation: A definition and predictors of outcome. National institute of diabetes and digestive and kidney diseases liver transplantation database. Transplantation 1998; 66: 302-10.
25. Maring JK, Klompmaker IJ, Zwaveling JH, et al. Poor initial graft function after orthotopic liver transplantation: Can it be predicted and does it affect outcome? An analysis of 125 adult primary transplantations. Clin Transplant 1997; 11: 373-9.
26. Gonzalez FX, Rimola A, Grande L, et al. Predictive factors of early postoperative graft function in human liver transplantation. Hepatology 1994; 20: 565-73.
27. Hetz H, Faybik P, Berlakovich G, et al. Molecular adsorbent recirculating system in patients with early allograft dysfunction after liver transplantation: A pilot study. Liver transpl 2006; 12: 1357-64.
28. Hanley JA, Mcneil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-43.
29. Conn HO. A peek at the Child-Turcotte classification. Hepatology 1981; 1: 673-6.
30. Ben-Ari Z, Weiss-Schmilovitz H, Sulkes J, et al. Serum cholestasis markers as predictors of early outcome after liver transplantation. Clin Transplant 2004; 18: 130-6.
31. Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996; 23: 164-76.
32. Cooper GS, Bellamy P, Dawson NV, et al. A prognostic model for patients with end-stage liver disease. Gastroenterology 1997; 113: 1278-88.
33. Gonwa TA, Klintmalm GB, Levy M, et al. Impact of pre-transplant renal function on survival after liver transplantation. Transplantation 1995; 59: 361-5.
34. Serra MA, Puchades MJ, Rodriguez F, et al. Clinical value of increased serum creatinine concentration as predictor of short-term outcome in decompensated cirrhosis. Scand J Gastroenterol 2004; 39: 1149-53.
35. Rice HE, O'keefe GE, Helton WS, et al. Morbid prognostic features in patients with chronic liver failure undergoing nonhepatic surgery. Arch Surg 1997; 132: 880-4.
36. Patzer II JF, Lopez RC, Zhu Y, et al. Bioartificial liver assist devices in support of patients with liver failure. Hepatobiliary Pancreat Dis Int 2002; 1: 18-25.
37. Liu YH, Wang Y, Yu LX, et al. Artificial liver support molecular adsorbents recirculating system therapy as a bridge to re-transplantation in two cases of long anhepatic duration. Hepatobiliary Pancreat Dis Int 2004; 3: 316-7.
38. Shen ZY, Zhu ZJ, Deng YL, et al. Liver retransplantation: Report of 80 cases and review of literature. Hepatobiliary Pancreat Dis Int 2006; 5: 180-4.
39. Zheng SS, Xu X, Liang TB, et al. Biliary complications following early hepatic arterial insufficiency in liver transplantation. Zhonghua Yi Xue Za Zhi 2005; 85: 1665-9.
40. Jiang ZJ, Zheng SS, Liang TB, et al. Retransplantation for liver transplanter with poor graft function. Zhonghua Wai Ke Za Zhi 2006; 44: 153-6.
41. Saab S, Wang V, Ibrahim AB, et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl 2003; 9: 473-6.
42. Gheorghe L, Popescu I, Iacob R, et al. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time. Transpl Int 2005; 18: 572-6.
43. Heuman DM, Mihas AA, Habib A, et al. MELD-XI: A rational approach to "sickest first"liver transplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transpl 2007; 13: 30-7.